Muscle Function Clinical Trial
Official title:
Does Exercise Snacking Improve Muscle Function in Older Adults?
NCT number | NCT02991989 |
Other study ID # | UoB-ESS-01 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 20, 2016 |
Est. completion date | July 2017 |
Verified date | May 2018 |
Source | University of Bath |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Muscle size declines at around 0.5-1% per year after 50 years of age, with muscle strength declining up to twice as fast as muscle size. This may eventually lead to loss of independence if tasks of daily living become too strenuous to be performed safely. Exercise is recognized as a safe and effective means to counteract muscle loss during aging, however access to gym equipment may be logistically challenging or unpalatable to older adults. This research is designed to investigate the effect of 28 days of home-based leg exercise that doesn't require exercise equipment or supervision (exercise snacking), accompanied with a daily protein supplement in the form of commercially available yogurt, on the skeletal muscle health (i.e. function and size) of independent, community-dwelling older adults. To achieve this, two groups will be compared; one group will undertake exercise snacking and consume a 150 g yogurt with the breakfast meal for four weeks, with the second group only receiving the daily yogurt with no exercise snacking.
Status | Completed |
Enrollment | 20 |
Est. completion date | July 2017 |
Est. primary completion date | June 1, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 65 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Not underweight or obese (body mass index =20 and = 30 kg/m2) - Not regularly engaging in recreational sports or structured exercise (once a week or more). - Non-smoker (for >5 years) - Healthy (see exclusion criteria) Exclusion Criteria: - Any chronic illness, cardiac, pulmonary, liver, or kidney abnormalities, uncontrolled hypertension, peripheral arterial disease, insulin- or non-insulin dependent diabetes or other metabolic disorders - all ascertained through preliminary screening. - Individuals with a history of bone, joint or neuromuscular problems or a current musculoskeletal injury ascertained through preliminary screening. - Individuals with any joint replacement surgical implants or other artifacts containing metal. - Individuals with a clinically diagnosed allergy or intolerance of dairy products. - Individuals with contraindications to exercise including chest pain, dizziness, or loss of consciousness, or who have been instructed by their doctor to only do physical activity recommended by them. - Individuals who score less than 8 on the Short Physical Performance Battery or score zero on any component of the test. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | University of Bath | Bath | Avon |
Lead Sponsor | Collaborator |
---|---|
University of Bath |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 60 second sit to stand test | The participant is asked to stand up from sitting in a chair whilst keeping their arms folded across their chest, then return to the seated position as many times as possible in a minute. | 28 days- change from pre- to post- intervention period | |
Secondary | Lower limb muscle power | Measured during leg pressing | 28 days- change from pre- to post- intervention period | |
Secondary | Lower limb movement outcome variability | Measured during leg pressing | 28 days- change from pre- to post- intervention period | |
Secondary | Lower limb muscle cross-sectional area | Measured using peripheral quantitative computed tomography at 66% distal calf length and 25% and 50% distal thigh length | 28 days- change from pre- to post- intervention period | |
Secondary | Lower limb muscle cross-sectional tissue density | Measured using peripheral quantitative computed tomography at 66% distal calf length and 25% and 50% distal thigh length | 28 days- change from pre- to post- intervention period | |
Secondary | Body composition | Measured using Dual Energy X-ray Absorptiometry | 28 days- change from pre- to post- intervention period | |
Secondary | Gastrocnemius and quadriceps muscle fibre pennation angle | Measured using ultrasonography at 66% distal length of calf length and 50% distal thigh length | 28 days- change from pre- to post- intervention period | |
Secondary | Gastrocnemius and quadriceps muscle fibre length | Measured using ultrasonography at 66% distal length of calf length and 50% distal thigh length | 28 days- change from pre- to post- intervention period | |
Secondary | Postural sway during standing balance with eyes open and closed | Measured using a force plate | 28 days- change from pre- to post- intervention period | |
Secondary | Single leg balance | Measured using the Y-balance test | 28 days- change from pre- to post- intervention period | |
Secondary | Six minute walk test | The participant will be asked to walk as many times between two cones places 15 meters apart as possible in six minutes. | 28 days- change from pre- to post- intervention period | |
Secondary | Movement co-ordination during walking and sit to stands | Measured by Qualisys motion capture and force plates | 28 days- change from pre- to post- intervention period | |
Secondary | Central drive of the plantar flexors | Measured through the interpolated twitch technique | 28 days- change from pre- to post- intervention period |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04300504 -
Muscle in Obesity: Imaging, Function and microRNA
|
||
Completed |
NCT01825616 -
Vitamin D2, Muscle Damage, NASCAR Pitcrew
|
N/A | |
Recruiting |
NCT06379282 -
Investigating the Role of Energy Balance Modification on Health Responses in Chronic Lymphocytic Leukaemia
|
N/A | |
Recruiting |
NCT06067477 -
Estimation of the Dietary Requirement for Vitamin D in Ethnic Groups
|
N/A | |
Completed |
NCT05929118 -
The Effect of Aquatic Rehabilitation on Knee Function in Anterior Cruciate Ligament Reconstruction Patients.
|
N/A | |
Completed |
NCT05397418 -
Female Muscle Enhancement
|
N/A | |
Not yet recruiting |
NCT04241497 -
Home-based Exercise Training in Patients With Pulmonary Arterial Hypertension: Effect on Skeletal Muscular Function and Metabolism
|
N/A | |
Completed |
NCT03956732 -
Effects of Milk Protein and Vitamin D on Children's Growth and Health
|
N/A | |
Completed |
NCT02655393 -
A Single and Multiple Dose Study of AMAZ-02 to Evaluate Safety and Pharmacokinetics in Elderly Subjects
|
Phase 1 | |
Completed |
NCT04563611 -
Effect of Exercises on Hamstring Muscle Function, Injury Risk, Agility and Cognitive Function
|
N/A | |
Completed |
NCT02858882 -
Vitamin D Status and Muscle Function
|
N/A | |
Completed |
NCT03283462 -
Bioenergetics and Muscle Function Improvement With AMAZ-02 in Elderly Skeletal Muscle (ENERGIZE Trial)
|
N/A | |
Completed |
NCT02819505 -
β-alanine Supplementation on Knee Extensor Contractile and Force Properties
|
Phase 4 | |
Completed |
NCT02317536 -
A Pilot Clinical Trial on the Efficacy of Two Carnitine-Based Products on Muscle Function in Healthy Older Adults
|
Phase 2 | |
Recruiting |
NCT05617222 -
The Impact of Bed Rest, Aging and NMES on Skeletal Muscle
|
N/A | |
Suspended |
NCT03111979 -
The Effects of 4 Week β-alanine Supplementation on Knee Extensor Contractile and Force Properties in the Over 60s
|
Phase 4 | |
Recruiting |
NCT04619784 -
Effect of Pilates Application on Abdominal Muscle Function, Core Stability, Musculoskeletal Pain, Quality of Life, Anxiety and Depression in Parkinson's Patients
|
N/A |